DMD and Duchenne muscular dystrophy: Alternatively, adeno-associated viral (AAV) gene therapy is under active investigation to express miniaturized dystrophin constructs in DMD patients due to the large size of the dystrophin gene and the limited capacity of AAV vectors [18-20].